4.3 Article

Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study

Journal

PEDIATRIC DIABETES
Volume 14, Issue 3, Pages 174-180

Publisher

WILEY-BLACKWELL
DOI: 10.1111/pedi.12003

Keywords

ABCC8; infant; INS; KCNJ11; neonatal diabetes

Funding

  1. Centers for Disease Control and Prevention [00097, DP-05-069, DP-10-001]
  2. National Institute of Diabetes and Digestive and Kidney Diseases
  3. Juvenile Diabetes Research Foundation [JDRF 9-2007-1700]
  4. European Union from FP7 integrated project CEED3
  5. European Union from Madam Curie initial funding network BOLD
  6. Peninsula NIHR Clinical Research Facility
  7. Kaiser Permanente Southern California [U48/CCU919219, U01 DP000246, U18DP002714]
  8. University of Colorado, Denver [U48/CCU819241-3, U01 DP000247, U18DP000247-06A1]
  9. Kuakini Medical Center [U58CCU919256, U01 DP000245]
  10. Children's Hospital Medical Center Cincinnati [U48/CCU519239, U01 DP000248, 1U18DP002709]
  11. University of North Carolina at Chapel Hill [U48/CCU419249, U01 DP000254, U18DP002708-01]
  12. University of Washington School of Medicine [U58/CCU019235-4, U01 DP000244, U18DP002710-01]
  13. Wake Forest University School of Medicine [U48/CCU919219, U01 DP000250, 200-2010-35171]
  14. NIH/NCRR [UL1RR029882]
  15. Children's Hospital and Regional Medical Center [M01RR00037]
  16. Colorado Pediatric General Clinical Research Center [M01 RR00069]
  17. Barbara Davis Center at the University of Colorado at Denver [DERC NIH P30 DK57516]
  18. Institutional Clinical and Translational Science Award (CTSA), NIH/NCRR at the University of Cincinnati [1UL1RR026314-01]
  19. National Institute for Health Research [NF-SI-0611-10219] Funding Source: researchfish

Ask authors/readers for more resources

Background Neonatal diabetes mellitus (NDM) is defined as diabetes with onset before 6months of age. Nearly half of individuals with NDM are affected by permanent neonatal diabetes mellitus (PNDM). Mutations in KATP channel genes (KCNJ11, ABCC8) and the insulin gene (INS) are the most common causes of PNDM. Objective To estimate the prevalence of PNDM among SEARCH for Diabetes in Youth (SEARCH) study participants (20012008) and to identify the genetic mutations causing PNDM. Methods SEARCH is a multicenter population-based study of diabetes in youth <20yr of age. Participants diagnosed with diabetes before 6months of age were invited for genetic testing for mutations in the KCNJ11, ABCC8, and INS genes. Results Of the 15,829 SEARCH participants with diabetes, 39 were diagnosed before 6months of age. Thirty-five of them had PNDM (0.22% of all diabetes cases in SEARCH), 3 had transient neonatal diabetes that had remitted by 18months and 1 was unknown. The majority of them (66.7%) had a clinical diagnosis of type1 diabetes by their health care provider. Population prevalence of PNDM in youth <20yr was estimated at 1 in 252000. Seven participants underwent genetic testing; mutations causing PNDM were identified in five (71%), (two KCNJ11, three INS). Conclusions We report the first population-based frequency of PNDM in the US based on the frequency of PNDM in SEARCH. Patients with NDM are often misclassified as having type1 diabetes. Widespread education is essential to encourage appropriate genetic testing and treatment of NDM.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

Recurrent 17q12 microduplications contribute to renal disease but not diabetes

Stuart Cannon, Rhian Clissold, Kittiya Sukcharoen, Marcus Tuke, Gareth Hawkes, Robin N. Beaumont, Andrew R. Wood, Mark Gilchrist, Andrew T. Hattersley, Richard A. Oram, Kashyap Patel, Caroline Wright, Michael N. Weedon

Summary: 17q12 microdeletion and microduplication syndromes are complex disorders with overlapping phenotypes, including diabetes, renal disease, and neurocognitive traits.

JOURNAL OF MEDICAL GENETICS (2023)

Article Health Care Sciences & Services

Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches

Nicholas J. Thomas, Andrew McGovern, Katherine G. Young, Seth A. Sharp, Michael N. Weedon, Andrew T. Hattersley, John Dennis, Angus G. Jones

Summary: This study aimed to compare the performance of different approaches for classifying insulin-treated diabetes without measured classification biomarkers. The results showed that combining early insulin requirement with a T1D probability model and interview-reported diabetes type achieved the highest accuracy.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2023)

Article Immunology

FOXP3 TSDR Measurement Could Assist Variant Classification and Diagnosis of IPEX Syndrome

Rebecca C. Wyatt, Sven Olek, Elisa De Franco, Bjoern Samans, Kashyap Patel, Jayne Houghton, Steffi Walter, Janika Schulze, Rosa Bacchetta, Andrew T. Hattersley, Sarah E. Flanagan, Matthew B. Johnson

Summary: By studying a large cohort of patients diagnosed with IPEX and using TSDR analysis, it was found that diagnosing IPEX at presentation with isolated diabetes can effectively monitor disease progression and predict the course of the disease. This method can aid in the classification and diagnosis of FOXP3 variants and allow for immune modulatory treatment to be initiated before the onset of severe enteropathy.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Article Pharmacology & Pharmacy

Circulating plasma phospholipid fatty acid levels as a biomarker of habitual dietary fat intake: The INTERMAP/INTERLIPID Study

Naoko Miyagawa, Akira Sekikawa, Katsuyuki Miura, Rhobert W. Evans, Nagako Okuda, Akira Fujiyoshi, Katsushi Yoshita, Queenie Chan, Yukiko Okami, Aya Kadota, Bradley Willcox, Kamal Masaki, Beatriz Rodriguez, Kiyomi Sakata, Hideaki Nakagawa, Shigeyuki Saitoh, Akira Okayama, Lewis H. Kuller, Paul Elliott, Jeremiah Stamler, Hirotsugu Ueshima

Summary: This study examined the association between plasma phospholipid fatty acid levels and dietary intake of fatty acids. The results showed a correlation between intake and circulating fatty acid levels, especially for marine-derived fatty acids. Plasma phospholipid measurements of marine-derived fatty acids can be used as a reliable biomarker for assessing dietary intake.

JOURNAL OF CLINICAL LIPIDOLOGY (2023)

Article Biochemistry & Molecular Biology

Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study

Beverley M. Shields, Catherine D. Angwin, Maggie H. Shepherd, Nicky Britten, Angus G. Jones, Naveed Sattar, Rury Holman, Ewan R. Pearson, Andrew T. Hattersley

Summary: Patient preference plays a crucial role in medication selection for chronic medical conditions like type 2 diabetes. Balancing potential efficacy and side effects, patient preference can inform treatment decisions based on personal experience with alternative medications. A recent study on type 2 diabetes patients compared three different glucose-lowering drugs and found that allocating therapy based on individual drug preference resulted in better glycemic control and fewer side effects compared to prescribing the overall most preferred drug.

NATURE MEDICINE (2023)

Article Biochemistry & Molecular Biology

Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study

Beverley M. M. Shields, John M. M. Dennis, Catherine D. D. Angwin, Fiona Warren, William E. E. Henley, Andrew J. J. Farmer, Naveed Sattar, Rury R. R. Holman, Angus G. G. Jones, Ewan R. R. Pearson, Andrew T. T. Hattersley

Summary: Precision medicine in type 2 diabetes aims to treat patients based on their clinical characteristics. This study examines the differential drug response in relation to body mass index (BMI) and estimated glomerular filtration rate (eGFR). The findings suggest that in obese patients, thiazolidinediones may be more effective in lowering glucose levels compared to DPP4 inhibitors, while in patients with eGFR of 60-90 ml/min/1.73 m², DPP4 inhibitors may be more effective than SGLT2 inhibitors in lowering glucose levels.

NATURE MEDICINE (2023)

Article Cell Biology

The Type 2 Diabetes Knowledge Portal: An open access genetic resource dedicated to type 2 diabetes and related traits

Maria C. Costanzo, Marcin von Grotthuss, Jeffrey Massung, Dongkeun Jang, Lizz Caulkins, Ryan Koesterer, Clint Gilbert, Ryan P. Welch, Parul Kudtarkar, Quy Hoang, Andrew P. Boughton, Preeti Singh, Ying Sun, Marc Duby, Annie Moriondo, Trang Nguyen, Patrick Smadbeck, Benjamin R. Alexander, MacKenzie Brandes, Mary Carmichael, Peter Dornbos, Todd Green, Kenneth C. Huellas-Bruskiewicz, Yue Ji, Alexandria Kluge, Aoife C. McMahon, Josep M. Mercader, Oliver Ruebenacker, Sebanti Sengupta, Dylan Spalding, Daniel Taliun, Philip Smith, Melissa K. Thomas, Beena Akolkar, M. Julia Brosnan, Andriy Cherkas, Audrey Y. Chu, Eric B. Fauman, Caroline S. Fox, Tania Nayak Kamphaus, Melissa R. Miller, Lynette Nguyen, Afshin Parsa, Dermot F. Reilly, Hartmut Ruetten, David Wholley, Norann A. Zaghloul, Goncalo R. Abecasis, David Altshuler, Thomas M. Keane, Mark I. McCarthy, Kyle J. Gaulton, Jose C. Florez, Michael Boehnke, Noel P. Burtt, Jason Flannick

Summary: This study aims to make the Type 2 Diabetes Knowledge Portal (T2DKP) more accessible and useful to both new and existing users. It evaluates the comprehensiveness of T2DKP by comparing its datasets with other repositories, guides researchers unfamiliar with human genetic data on how to interpret and use the data through T2DKP, and discusses the importance of democratizing access to complex disease genetic results.

CELL METABOLISM (2023)

Correction Endocrinology & Metabolism

The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis (vol 66, pg 300, 2023)

Katherine G. Young, Andrew P. McGovern, Ines Barroso, Andrew T. Hattersley, Angus G. Jones, Beverley M. Shields, Nicholas J. Thomas, John M. Dennis

DIABETOLOGIA (2023)

Letter Endocrinology & Metabolism

HbA1c screening for the diagnosis of diabetes. Reply to Broz J, Brabec M, Krollova P et al [letter]

Katherine G. Young, Andrew P. McGovern, Ines Barroso, Andrew T. Hattersley, Angus G. Jones, Beverley M. Shields, Nicholas J. Thomas, John M. Dennis

DIABETOLOGIA (2023)

Article Public, Environmental & Occupational Health

Sun Exposure and Intima-Media Thickness in the Mexican Teachers' Cohort Study

Mercedes Aguilar, Paloma Munoz-Aguirre, Adrian Cortes-Valencia, Mario H. Flores-Torres, Andres Catzin-Kuhlmann, Ruy Lopez-Ridaura, Martin Lajous, Beatriz L. Rodriguez, Carlos Cantu-Brito, Edgar Denova-Gutierrez

Summary: This study aimed to determine whether long-term sun exposure has a protective role in subclinical cardiovascular disease in adult Mexican women. The results showed an inverse association between sun exposure and carotid intima-media thickness (IMT) as well as subclinical carotid atherosclerosis. If further studies confirm these findings for other cardiovascular outcomes, sun exposure could be an affordable strategy to lower overall cardiovascular risk.

JOURNAL OF WOMENS HEALTH (2023)

Article Genetics & Heredity

Inspiring New Science to Guide Healthcare in Turner Syndrome: Rationale, design, and methods for the InsighTS Registry

Roopa Kanakatti Shankar, Alexandra Carl, Jennifer R. Law, Vaneeta Bamba, Wendy J. Brickman, Siddharth K. Prakash, Tazim Dowlut McElroy, Susan Howell, Iris Gutmark Little, Karen O. Klein, Catherina T. Pinnaro, Kelly Ranallo, Marybel Good, Shanlee M. Davis

Summary: The InsighTS registry is designed to collect and store validated longitudinal clinical data from individuals with Turner syndrome (TS). The registry aims to improve health outcomes for this population and involves multiple stakeholders to ensure its relevance and sustainability. It gathers various clinical data and future plans include patient-centered clinical-translational research projects.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Editorial Material Medical Laboratory Technology

Laboratory Guidelines Are Needed for Diagnostic Genetic Testing for Monogenic Diabetes

Andrew T. Hattersley

CLINICAL CHEMISTRY (2023)

Article Endocrinology & Metabolism

Anti-Mullerian hormone and spontaneous puberty in a diverse US Turner syndrome clinic cohort: A cross-sectional study

Victoria H. Bustamante, Despoina M. Galetaki, Tazim Dowlut-McElroy, Roopa Kanakatti Shankar

Summary: This study aimed to investigate the distribution of serum Anti-Mullerian Hormone (AMH) in patients with Turner syndrome (TS) and its correlation with karyotype, spontaneous puberty, and gonadotropins during minipuberty. The results showed a correlation between AMH and karyotype as well as spontaneous puberty, and highlighted the clinical relevance of gonadotropins during minipuberty.

CLINICAL ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing

Alice E. Hughes, Jayne A. L. Houghton, Benjamin Bunce, Ali J. Chakera, Gill Spyer, Maggie H. Shepherd, Sarah E. Flanagan, Andrew T. Hattersley

Summary: In pregnancies with maternal glucokinase-MODY (GCK-MODY), fetal growth is determined by fetal genotype. A non-invasive prenatal testing of fetal GCK genotype (NIPT-GCK) using cell-free DNA in maternal blood has been developed. This study compared the diagnostic accuracy of NIPT-GCK with ultrasound and assessed the feasibility of using NIPT-GCK for pregnancy management.

DIABETOLOGIA (2023)

Article Endocrinology & Metabolism

Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

Adem Y. Dawed, Andrea Mari, Andrew Brown, Timothy J. McDonald, Lin Li, Shuaicheng Wang, Mun-Gwan Hong, Sapna Sharma, Neil R. Robertson, Anubha Mahajan, Xuan Wang, Mark Walker, Stephen Gough, Leen M. 't Hart, Kaixin Zhou, Ian Forgie, Hartmut Ruetten, Imre Pavo, Pallav Bhatnagar, Angus G. Jones, Ewan R. Pearson, for the D. I. R. E. C. T. consortium DIRECT consortium

Summary: This study identified genetic variants associated with the response to GLP-1 receptor agonist treatment in patients with type 2 diabetes, which provides valuable insights for clinical decision making and personalized medicine.

LANCET DIABETES & ENDOCRINOLOGY (2023)

No Data Available